Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase…
Biotechnology
US, Cardiff-by-the-Sea [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Viracta Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Viracta Therapeutics, Inc. has no acquisition track records yet.